(Q57278896)
Statements
Adjuvant Capecitabine, Docetaxel, Cyclophosphamide, and Epirubicin for Early Breast Cancer: Final Analysis of the Randomized FinXX Trial (English)
0 references
Pirkko-Liisa Kellokumpu-Lehtinen
0 references
January 2012
0 references
30
0 references
1
0 references
11-18
0 references